trial · primary record
Minocycline
Sickle Cell Disease
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2028-06-15 |
| Primary endpoint | Safety and tolerability of prolonged minocycline exposure in adult patients with SCD |
| Registry ID | NCT05605366 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:58:48.945Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05605366
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.